Register Login
Register to leave comments
  • News bot Aug. 17, 2026, 12:11 p.m.

    📋 ANAVEX LIFE SCIENCES CORP. (AVXL) - Regulatory Update

    Filing Date: 2026-08-17

    Accepted: 2026-08-17 08:10:44

    Event Type: Regulatory Update

    Event Details:

    ANAVEX LIFE SCIENCES CORP. (AVXL) Announces Regulatory Update ANAVEX LIFE SCIENCES CORP. (AVXL) provided an update on regulatory developments for its product portfolio. Regulatory Update Details: • Regulatory Agencies: EMA (European Medicines Agency) Clinical Development:

    🔬 Clinical Development Pipeline (ANAVEX LIFE SCIENCES CORP.):

    Product Type Development Stage Therapeutic Area Source
    ANAVEX2-73 Oral Other Phase PHASE2 Alzheimer's Disease ClinicalTrials.gov
    ANAVEX2-73 Intravenous Other Phase PHASE2 Alzheimer's Disease ClinicalTrials.gov
    Placebo Other Phase PHASE2 Rett Syndrome ClinicalTrials.gov
    ANAVEX2-73 Other Phase PHASE2 Rett Syndrome ClinicalTrials.gov
    Placebo oral capsules Other Phase PHASE2 Schizophrenia ClinicalTrials.gov
    ANAVEX3-71 oral capsules Other Phase PHASE2 Schizophrenia ClinicalTrials.gov
    Placebo oral capsule Other Phase PHASE2 Parkinsons Disease With Dementia ClinicalTrials.gov
    Mid dose ANAVEX2-73 Other Phase PHASE2 Parkinsons Disease With Dementia ClinicalTrials.gov
    High dose ANAVEX2-73 Other Phase PHASE2 Parkinsons Disease With Dementia ClinicalTrials.gov
    ANAVEX3-71 Other Phase PHASE1 Healthy ClinicalTrials.gov
    Placebo oral liquid Other Phase PHASE2 Rett Syndrome ClinicalTrials.gov
    ANAVEX2-73 oral liquid Other Phase PHASE2 Rett Syndrome ClinicalTrials.gov
    Ketamine DRUG Phase EARLY_PHASE1 Healthy ClinicalTrials.gov

    💼 Business Developments:

    • Partnership: Not available
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: ANAVEX LIFE SCIENCES CORP.
    • Ticker Symbol: AVXL

Search

News categories